Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dengue | 14 | 2023 | 93 | 3.710 |
Why?
|
| Macaca mulatta | 21 | 2023 | 122 | 3.350 |
Why?
|
| Dengue Virus | 14 | 2023 | 84 | 2.700 |
Why?
|
| Antibodies, Viral | 15 | 2024 | 252 | 2.250 |
Why?
|
| Antibodies, Neutralizing | 11 | 2024 | 102 | 1.960 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 23 | 1.570 |
Why?
|
| Antibody-Dependent Enhancement | 2 | 2017 | 3 | 1.260 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 68 | 0.920 |
Why?
|
| Immunity, Innate | 4 | 2020 | 135 | 0.890 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 232 | 0.890 |
Why?
|
| Interferons | 2 | 2013 | 34 | 0.780 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 341 | 0.760 |
Why?
|
| Genes, MHC Class I | 1 | 2018 | 13 | 0.670 |
Why?
|
| Genes, MHC Class II | 1 | 2018 | 20 | 0.670 |
Why?
|
| Gene Frequency | 1 | 2018 | 155 | 0.640 |
Why?
|
| Flaviviridae Infections | 1 | 2017 | 1 | 0.640 |
Why?
|
| Dengue Vaccines | 4 | 2021 | 13 | 0.640 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 179 | 0.640 |
Why?
|
| Flavivirus | 1 | 2017 | 10 | 0.630 |
Why?
|
| Cytokines | 6 | 2019 | 569 | 0.610 |
Why?
|
| Viral Envelope Proteins | 7 | 2023 | 77 | 0.610 |
Why?
|
| Puerto Rico | 6 | 2021 | 1352 | 0.590 |
Why?
|
| Vaccination | 4 | 2024 | 259 | 0.590 |
Why?
|
| Animals | 24 | 2023 | 14307 | 0.580 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 2019 | 55 | 0.530 |
Why?
|
| Serine Endopeptidases | 2 | 2019 | 36 | 0.520 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2019 | 45 | 0.500 |
Why?
|
| Immune Evasion | 1 | 2013 | 16 | 0.480 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 40 | 0.470 |
Why?
|
| Simian immunodeficiency virus | 5 | 2019 | 56 | 0.460 |
Why?
|
| Male | 16 | 2023 | 18870 | 0.420 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2011 | 3 | 0.410 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2011 | 3 | 0.410 |
Why?
|
| Cross Reactions | 4 | 2021 | 83 | 0.410 |
Why?
|
| Breeding | 2 | 2016 | 21 | 0.410 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2011 | 8 | 0.410 |
Why?
|
| Specific Pathogen-Free Organisms | 3 | 2018 | 19 | 0.380 |
Why?
|
| Meningoencephalitis | 1 | 2009 | 13 | 0.360 |
Why?
|
| Humans | 23 | 2024 | 34853 | 0.360 |
Why?
|
| Mycobacterium Infections | 1 | 2009 | 16 | 0.360 |
Why?
|
| Virus Replication | 1 | 2011 | 261 | 0.350 |
Why?
|
| Herpesvirus 1, Cercopithecine | 2 | 2006 | 3 | 0.340 |
Why?
|
| Vagina | 2 | 2019 | 81 | 0.290 |
Why?
|
| Dendritic Cells | 2 | 2020 | 112 | 0.290 |
Why?
|
| Microsatellite Repeats | 2 | 2017 | 51 | 0.290 |
Why?
|
| Immunity | 2 | 2019 | 51 | 0.290 |
Why?
|
| Cervix Uteri | 2 | 2019 | 43 | 0.290 |
Why?
|
| Genetics, Population | 2 | 2017 | 66 | 0.290 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 164 | 0.290 |
Why?
|
| Time Factors | 3 | 2020 | 1681 | 0.280 |
Why?
|
| Monkey Diseases | 1 | 2005 | 6 | 0.270 |
Why?
|
| Herpesviridae Infections | 1 | 2005 | 18 | 0.260 |
Why?
|
| Genetic Variation | 2 | 2017 | 328 | 0.250 |
Why?
|
| Social Alienation | 1 | 2023 | 4 | 0.240 |
Why?
|
| HLA-DR Antigens | 1 | 2023 | 20 | 0.240 |
Why?
|
| Neutralization Tests | 2 | 2021 | 53 | 0.240 |
Why?
|
| Viremia | 3 | 2019 | 40 | 0.240 |
Why?
|
| Female | 11 | 2023 | 19873 | 0.230 |
Why?
|
| AIDS Vaccines | 3 | 2007 | 30 | 0.210 |
Why?
|
| Caribbean Region | 2 | 2016 | 63 | 0.210 |
Why?
|
| Cross Protection | 1 | 2021 | 4 | 0.210 |
Why?
|
| RNA, Viral | 3 | 2001 | 287 | 0.200 |
Why?
|
| Mucous Membrane | 2 | 2019 | 34 | 0.200 |
Why?
|
| K562 Cells | 2 | 2017 | 31 | 0.190 |
Why?
|
| Immunologic Factors | 1 | 2020 | 44 | 0.190 |
Why?
|
| Semen | 1 | 2019 | 48 | 0.180 |
Why?
|
| RNA, Messenger | 1 | 2024 | 1152 | 0.180 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 964 | 0.170 |
Why?
|
| Animals, Laboratory | 1 | 2018 | 2 | 0.170 |
Why?
|
| Protein Binding | 1 | 2021 | 913 | 0.170 |
Why?
|
| Mutation | 2 | 2021 | 1023 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 251 | 0.160 |
Why?
|
| Primate Diseases | 1 | 2017 | 4 | 0.160 |
Why?
|
| Vaccines, DNA | 3 | 2007 | 23 | 0.160 |
Why?
|
| Haplotypes | 1 | 2018 | 152 | 0.160 |
Why?
|
| Animal Population Groups | 1 | 2017 | 1 | 0.160 |
Why?
|
| Animals, Wild | 1 | 2017 | 15 | 0.160 |
Why?
|
| Immune Sera | 1 | 2017 | 59 | 0.160 |
Why?
|
| Pedigree | 1 | 2017 | 64 | 0.150 |
Why?
|
| Alleles | 1 | 2018 | 284 | 0.150 |
Why?
|
| Cell Line | 2 | 2019 | 1289 | 0.150 |
Why?
|
| Models, Animal | 1 | 2017 | 131 | 0.150 |
Why?
|
| Genetic Drift | 1 | 2016 | 3 | 0.140 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2015 | 10 | 0.140 |
Why?
|
| Lymph Nodes | 2 | 2007 | 67 | 0.120 |
Why?
|
| Adult | 4 | 2021 | 11034 | 0.120 |
Why?
|
| Serologic Tests | 2 | 2022 | 43 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 57 | 0.120 |
Why?
|
| Endometrium | 1 | 2014 | 57 | 0.120 |
Why?
|
| Inflammation | 2 | 2023 | 577 | 0.120 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2013 | 9 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2011 | 392 | 0.110 |
Why?
|
| Serotyping | 2 | 2014 | 36 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 224 | 0.110 |
Why?
|
| HIV-1 | 3 | 2007 | 678 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2013 | 121 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1442 | 0.100 |
Why?
|
| Interleukin-18 | 1 | 2010 | 13 | 0.100 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 14 | 0.100 |
Why?
|
| Interleukin-12 | 1 | 2010 | 46 | 0.100 |
Why?
|
| Morphine Dependence | 1 | 2010 | 25 | 0.100 |
Why?
|
| Middle Aged | 3 | 2021 | 9642 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 1124 | 0.090 |
Why?
|
| Aged | 1 | 2021 | 6448 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2009 | 38 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 445 | 0.090 |
Why?
|
| Granuloma | 1 | 2009 | 23 | 0.090 |
Why?
|
| Genetics | 1 | 2007 | 7 | 0.080 |
Why?
|
| Epidemiology | 1 | 2007 | 6 | 0.080 |
Why?
|
| Vaccines, Attenuated | 2 | 2019 | 72 | 0.080 |
Why?
|
| Digestive System | 1 | 2007 | 19 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 1490 | 0.080 |
Why?
|
| Simian T-lymphotropic virus 1 | 1 | 2006 | 6 | 0.080 |
Why?
|
| Marburgvirus | 1 | 2006 | 6 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2006 | 67 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2007 | 171 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 150 | 0.070 |
Why?
|
| Vaccinia virus | 1 | 2006 | 10 | 0.070 |
Why?
|
| Ebolavirus | 1 | 2006 | 42 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2006 | 100 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 298 | 0.070 |
Why?
|
| Animal Husbandry | 1 | 2005 | 14 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2006 | 213 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 77 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 352 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 550 | 0.060 |
Why?
|
| Cuba | 2 | 2001 | 32 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 600 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 555 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 605 | 0.060 |
Why?
|
| Child | 3 | 2015 | 2875 | 0.050 |
Why?
|
| Algorithms | 1 | 2005 | 435 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 18 | 0.050 |
Why?
|
| Aging | 1 | 2006 | 639 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 841 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2021 | 42 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 968 | 0.050 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2001 | 1 | 0.050 |
Why?
|
| Hepatitis A | 1 | 2001 | 10 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1300 | 0.050 |
Why?
|
| Mice | 3 | 2021 | 5668 | 0.050 |
Why?
|
| Base Sequence | 2 | 1999 | 932 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 1999 | 24 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 1999 | 12 | 0.050 |
Why?
|
| Autopsy | 1 | 1999 | 40 | 0.050 |
Why?
|
| RNA Helicases | 1 | 2019 | 16 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 608 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2019 | 59 | 0.040 |
Why?
|
| HIV Infections | 2 | 2019 | 2207 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 211 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 641 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 192 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 269 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 74 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 221 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 1999 | 155 | 0.040 |
Why?
|
| Liver | 1 | 1999 | 447 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1530 | 0.040 |
Why?
|
| Phylogeny | 1 | 1999 | 612 | 0.040 |
Why?
|
| Colombia | 1 | 2015 | 19 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 34 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2015 | 1318 | 0.040 |
Why?
|
| Thailand | 1 | 2015 | 48 | 0.040 |
Why?
|
| Singapore | 1 | 2015 | 72 | 0.030 |
Why?
|
| Safety | 1 | 2015 | 48 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 269 | 0.030 |
Why?
|
| United States | 1 | 2005 | 3894 | 0.030 |
Why?
|
| Plasma | 1 | 2014 | 29 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 1999 | 1961 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 185 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 233 | 0.030 |
Why?
|
| Macaca | 1 | 2013 | 38 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 97 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2013 | 72 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 383 | 0.030 |
Why?
|
| Viral Load | 1 | 2014 | 300 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 376 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 154 | 0.030 |
Why?
|
| Infant | 1 | 2015 | 1014 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 485 | 0.030 |
Why?
|
| Genes | 1 | 2007 | 58 | 0.020 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2007 | 3 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 31 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2007 | 17 | 0.020 |
Why?
|
| Rectum | 1 | 2007 | 22 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 159 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2007 | 44 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 96 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 23 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2007 | 116 | 0.020 |
Why?
|
| Administration, Rectal | 1 | 2006 | 17 | 0.020 |
Why?
|
| Africa, Western | 1 | 2005 | 7 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2005 | 12 | 0.020 |
Why?
|
| Gene Products, env | 1 | 2005 | 23 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4012 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2005 | 73 | 0.020 |
Why?
|
| Epitopes | 1 | 2005 | 145 | 0.020 |
Why?
|
| Adolescent | 1 | 2015 | 5035 | 0.020 |
Why?
|
| Monocytes | 1 | 2007 | 258 | 0.020 |
Why?
|
| Plasmids | 1 | 2005 | 233 | 0.020 |
Why?
|
| Transfection | 1 | 2005 | 496 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 322 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 2001 | 49 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2001 | 49 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 257 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 310 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2001 | 103 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1317 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 430 | 0.010 |
Why?
|